HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 34.71

Change

+0.24 (+0.70)%

Market Cap

USD 10.02B

Volume

0.02B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Hims & Hers Health, Inc. operates a platform that connects patients to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services through its websites and mobile applications. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; prescription generic, brand-name and compounded medications; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care. In addition, the company offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
UL Unilever PLC ADR

-0.96 (-1.59%)

USD 138.03B
KMB Kimberly-Clark Corporation

-3.31 (-2.25%)

USD 44.91B
CHD Church & Dwight Company Inc

-1.01 (-0.89%)

USD 26.34B
CLX The Clorox Company

+0.37 (+0.25%)

USD 18.61B
COTY Coty Inc

-0.33 (-5.48%)

USD 5.01B
ELF ELF Beauty Inc

-4.52 (-6.10%)

USD 4.12B
SPB Spectrum Brands Holdings Inc

-0.98 (-1.32%)

USD 1.98B
EPC Edgewell Personal Care Co

-0.42 (-1.31%)

USD 1.54B
PZC PIMCO California Municipal Inc..

N/A

USD 0.63B
YSG Yatsen Holding

+0.03 (+0.75%)

USD 0.38B

ETFs Containing HIMS

EDOG:LSE Global X Telemedicine & D.. 10.75 % 0.00 %

-0.15 (0.14%)

USD 0.36M
EDOC:LSE Global X Telemedicine & D.. 10.49 % 0.00 %

-0.17 (0.14%)

USD 3.99M
ULTY Tidal Trust II 7.50 % 0.00 %

+0.10 (+0.14%)

USD 0.28B
EDOC Global X Telemedicine & D.. 6.54 % 0.00 %

+0.10 (+0.14%)

USD 0.04B
EDOC:AU BetaShares Digital Health.. 4.99 % 0.00 %

N/A

N/A
FDHT Fidelity Covington Trust .. 4.69 % 0.00 %

-0.04 (0.14%)

USD 8.72M
DDOC:F Global X Telemedicine & D.. 4.59 % 0.00 %

-0.23 (0.14%)

N/A
EDOC:SW Global X Telemedicine & D.. 4.40 % 0.00 %

-0.10 (0.14%)

N/A
FCUS Pinnacle Focused Opportun.. 4.30 % 0.00 %

+0.51 (+0.14%)

USD 0.04B
EKG First Trust Nasdaq Lux Di.. 3.51 % 0.00 %

+0.06 (+0.14%)

USD 2.77M
FDOC:LSE 3.42 % 0.00 %

N/A

N/A
IJT iShares S&P Small-Cap 600.. 1.01 % 0.25 %

-0.23 (0.14%)

USD 5.97B
QVMS Invesco Exchange-Traded F.. 0.64 % 0.00 %

-0.10 (0.14%)

USD 0.19B
IJR iShares Core S&P Small-Ca.. 0.52 % 0.07 %

-0.58 (0.14%)

USD 81.25B
SPSM SPDR® Portfolio S&P 600 .. 0.52 % 0.06 %

-0.21 (0.14%)

USD 11.39B
IDP6:SW iShares S&P SmallCap 600 .. 0.51 % 0.00 %

-1.47 (0.14%)

USD 2.83B
RFLR Innovator ETFs Trust 0.30 % 0.00 %

+0.03 (+0.14%)

USD 0.01B
FAD First Trust Multi Cap Gro.. 0.00 % 0.69 %

+0.52 (+0.14%)

USD 0.24B
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

+0.68 (+0.14%)

N/A
IBUY Amplify Online Retail ETF 0.00 % 0.65 %

-0.38 (0.14%)

USD 0.19B
SAA ProShares Ultra SmallCap6.. 0.00 % 0.95 %

-0.14 (0.14%)

USD 0.04B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

+0.14 (+0.14%)

USD 0.08B
ISP6:LSE iShares III Public Limite.. 0.00 % 0.00 %

-134.50 (0.14%)

USD 3.07B
XRSG:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

-437.00 (0.14%)

USD 2.15B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

-4.07 (0.14%)

USD 2.11B
ROSC Hartford Multifactor Smal.. 0.00 % 0.00 %

-0.03 (0.14%)

USD 0.03B
2B77:XETRA iShares Ageing Population.. 0.00 % 0.00 %

-0.16 (0.14%)

USD 0.50B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

-1.78 (0.14%)

USD 0.09B
BBSC JPMorgan BetaBuilders U.S.. 0.00 % 0.00 %

+0.14 (+0.14%)

USD 0.49B
DDOC:XETRA Global X Telemedicine & D.. 0.00 % 0.00 %

-0.23 (0.14%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 43.55% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.55% 100% F 99% N/A
Trailing 12 Months  
Capital Gain 137.41% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 137.41% 100% F 99% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 49.43% 94% A 94% A
Dividend Return 49.43% 76% C+ 93% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 98.88% 6% D- 8% B-
Risk Adjusted Return 49.99% 71% C- 63% D
Market Capitalization 10.02B 69% C- 86% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.